Paclitaxel
NDC 68001-705, Paclitaxel, injection, from BluePoint Laboratories.
- Product NDC
- 68001-705
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216874
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PACLITAXEL6 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-705-27 | 68001070527 | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-705-27) / 50 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/59906bd2-8337-4cd8-9288-65b90eac2a7aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-705
Use it
Look up 68001-705 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.